Novonix (NVNXF) Notes Payables (2020 - 2025)

Novonix has reported Notes Payables for 6 years, with the latest figure at $62.1 million in Q4 2025.

• For the quarter ending Q4 2025, Notes Payables rose 96.0% year-over-year to $62.1 million; the trailing twelve-month figure through Dec 2025 stood at $62.1 million (up 96.0% YoY), and the FY2025 full-year result was $62.1 million, up 96.0% from the prior year.
• Notes Payables for Q4 2025 stood at $62.1 million, up from $31.7 million in the prior quarter.
• The five-year high for Notes Payables was $62.1 million in Q4 2025, with the low at $213351.5 in Q2 2021.
• Historically, Notes Payables has averaged $21.1 million across 5 years, with a median of $16.0 million in 2024.
• Annual changes were most pronounced in 2021 — Notes Payables advanced 12.84% — and 2024, when it soared 3555.73%.
• Novonix's Notes Payables stood at $213351.5 in 2021, then jumped by 394.88% to $1.1 million in 2022, then fell by 17.95% to $866278.0 in 2023, then soared by 3555.73% to $31.7 million in 2024, then soared by 96.0% to $62.1 million in 2025.
• The last three Notes Payables figures came in at $62.1 million (Q4 2025), $31.7 million (Q4 2024), and $30.9 million (Q2 2024), per Business Quant data.